Micrus Endovascular to Present at 2^nd Annual Jefferies Healthcare Conference

SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (NASDAQ:MEND) today announced that Robert Stern, President and COO, will present at the Jefferies 2^nd Annual Healthcare Conference on Thursday, June 26 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time).

A live audio webcast of the conference presentation will be available via the Internet by visiting the Investor Relations section of Micrus’ Web site at www.micruscorp.com. An archive of the presentation will be available on the Web site for 14 days.

About Micrus Endovascular Corporation

Micrus develops, manufactures and markets implantable and disposable medical devices for use in the treatment of cerebral vascular diseases. Micrus products are used by interventional neuroradiologists, interventional neurologists and neurosurgeons to treat both cerebral aneurysms responsible for hemorrhagic stroke and intracranial atherosclerosis, which may lead to ischemic stroke. Hemorrhagic and ischemic stroke are both significant causes of death and disability worldwide. The Micrus product line enables physicians to gain access to the brain in a minimally invasive manner through the vessels of the circulatory system. Micrus’ proprietary, three-dimensional microcoils automatically deploy within the aneurysm, forming a scaffold that conforms to a wide diversity of aneurysm shapes and sizes. Micrus also sells accessory devices and products used in conjunction with its microcoils. For more information, visit www.micruscorp.com.